Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-07-22
1994-04-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 31675
Patent
active
053025857
ABSTRACT:
The present invention provides chiral nucleotide analogs having the Formulas I and II ##STR1## and pharmaceutically acceptable salts and solvates thereof, and their pharmaceutical compositions for use in the treatment of viral infections, especially those caused by human immunodeficiency virus (HIV).
REFERENCES:
patent: 4659825 (1987-04-01), Holy et al.
patent: 4724233 (1988-02-01), DeClerq et al.
patent: 4808716 (1989-02-01), Holy et al.
Chemical Abstracts 109:190136p (1988).
Formula Index vol. 109, 1988, p. 830F (col. 1).
Holy et al, "Synthesis and evaluation of acyclic nucleotide analogs", Chemical Abstract, vol. 111:23866m, (1989).
Martin et al., "Synthesis and antiherpesvirus activity of (S)-1 ((3-hydroxy-2-phosphonylmethoxy)propyl.)cytosine (HPMPC) and related nucleotide analogues", Nucleosides & Nucleotides, vol. 8(5&6):923-926, (1989).
Rosenberg et al., "Acyclic nucleotide analogs. IV. Phosphonyl methoxyalkyl and phosphonylalkyl derivatives of adenine", Chemical Abstract, vol. 111:174565p, (1989).
DeClerq et al., "(S)-9-(2,3-dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity," Science, 200:563-565 (May 5, 1978).
Yang et al., "New Antiretroviral Acyclic Nucleotide Analog: (R)-2'-Me-PMEG ((R)-N(2-phosphonylmethoxypropylguanine)," Antiviral Research, Program & Abstracts of 4th International Conference on Antiviral Research, New Orleans, Apr. 21-26, 1991, Abstract 162 on p. 131.
Prisbe et al., "Synthesis and Antiherpes Virus Activity of Phosphate and Phosphonate Derivatives of 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine," J. Med. Chem. (1986) 29:671-675.
DeClerq et al, "A novel selective broad-spectrum anti-DNA virus agent," Nature (1986) 323:464-467.
DeClerq et al., "Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines," Antiviral Research (1987) 8:261-272.
Holy et al., "3-O-Phosphonylmethyl-9-(S)-(2,3-dihydroxypropyl)adenine novel type of biologially active nucleotide analogue," Nucl. Acids Res., Symposium Series 14 (1984) pp. 277-278.
Bronson et al., "Synthesis and Antiviral Activity of Phosphonylmethoxyethyl Derivatives of Purine and Pyrimidine Bases" Nucleotide Analogs as Antiviral Agents, ACS Symposium Series 401 (1989), Chapter 5, pp. 72-87 (Martin, J. C. ed.).
Kim et al., "Acyclic Purine Phosphonate Analogues as Antiviral Agents. Synthesis and Structure-Activity Relationships," J. Med. Chem. (1990) 33:1207-1213.
Bronson Joanne J.
Martin John C.
Yu Kuo-Long
Goldberg Jerome D.
Institute of Organic Chemistry and Biochemistry of the Academy o
Rega Stichting v.z.w.
LandOfFree
Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2098755